Position in NYXH
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$3,929
-$2,860 QoQ
Shares Held
2,325
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 45 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NYXH Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $6,023,152 across 52 Medical Devices names. NYXH ranks #46 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TXG |
10x Genomics, Inc.
|
29,559 | $1,133,292 | |
| 2 | EW |
Edwards Lifesciences Corp
|
5,366 | $485,408 | |
| 3 | PHG |
Koninklijke Philips NV
|
15,108 | $410,786 | |
| 4 | GMED |
Globus Medical Inc
|
3,842 | $303,556 | |
| 5 | MDT |
Medtronic plc
|
3,816 | $298,525 | |
| 6 | ABT |
Abbott Laboratories
|
3,264 | $296,175 | |
| 7 | ITGR |
Integer Holdings Corp
|
3,114 | $291,003 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
3,754 | $240,293 |
All Filings in NYXH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,929 | 2,325 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $6,789 | 2,325 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $10,695 | 2,325 | Shares | Sole | 2026-01-08 | |
| No filing history on record for this holder in this stock. | ||||||